tiprankstipranks

Perry Tsergas Insider Profile

4 Followers
Perry Tsergas, Director at PharmAla Biotech Holdings, Inc., holds 318.50K shares in PharmAla Biotech Holdings, Inc. (Ticker: TSE:MDMA).
tipranks
Perry  Tsergas

Perry Tsergas
PharmAla Biotech Holdings, Inc. (MDMA)
Director

Not Ranked
Perry Tsergas has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$75K
100.00%
A breakdown of Perry Tsergas's holdings

Insider Roles

PharmAla Biotech Holdings, Inc.
(MDMA)
Director
Roles that Perry Tsergas holds in companies

Most Profitable Insider Trade

Stock:
PharmAla Biotech Holdings, Inc.
(MDMA)
Rating:Informative Sell
Date:Nov 26, 2024 - Today
Return:+22.90%
The most profitable trade made by Perry Tsergas

Perry Tsergas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PharmAla Biotech Holdings, Inc.
Dec 11, 2024
Director
Uninformative Sell
C$74.85K
Success Rate for
MDMA
1 out of 1 profitable transactions on
MDMA
100%
Average Return for
MDMA
Average return per transaction on
MDMA
+22.90%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 22, 2024
Uninformative Sell
C$12.50K
-
C$0.05
Nov 26, 2024
Informative Sell
C$12.76K
-
C$0.29
+22.90%
Dec 03, 2024
Uninformative Sell
C$0.00
-
C$0.00
Dec 11, 2024
Uninformative Sell
C$0.00
-
C$0.00
List of latest transactions for each holding click on a transaction to see Perry Tsergas's performance on stock

Perry Tsergas insider profile FAQ

What is the percentage of profitable transactions made by Perry Tsergas?
The percentage of profitable transactions made by Perry Tsergas is ―.
    What is the average return per transaction made by Perry Tsergas?
    The average return per transaction made by Perry Tsergas is ―.
      What stocks does Perry Tsergas hold?
      Perry Tsergas holds: TSE:MDMA stocks.
        What was Perry Tsergas’s latest transaction?
        Perry Tsergas latest transaction was an Uninformative Sell of ―.
          What was Perry Tsergas's most profitable transaction?
          Perry Tsergas’s most profitable transaction was an Informative Sell of TSE:MDMA stock on November 26, 2024. The return on the trade was 22.90%.
            What is Perry Tsergas's role in PharmAla Biotech Holdings, Inc.?
            Perry Tsergas's role in PharmAla Biotech Holdings, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.